StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
RANC.JK$525.00-1.87%
Fair $525.00+0.0%

RANC.JK

PT Supra Boga Lestari Tbk

Consumer Defensive / Grocery StoresJakarta

$525.00

-10.00 (-1.87%)

Fairly Valued+0.0%Fair Value $525.00Fund rank 25/100 · Data gapFallback financials|
SA 29/D
F-Score: 2/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 26% · confianza 25%

FCF escenarios

weak_data · normalized FCF $43.7B · quality 42.3/100

Data gap 25/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 46/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

29/100

D

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

8/100

SEC 0%

Latest source: unknownPeriods: 2Warnings: 1unknown: 2
No SEC-backed annual rows; valuation uses fallback financial data. Limited financial history; valuation confidence should be treated as provisional. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -20.2%, below the 5% threshold
Thesis & Journal · RANC.JKLocal privado en este navegador · PT Supra Boga Lestari Tbk
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$821.4B

P/E

N/A

•

EV/EBITDA

8.4x

↓

ROE

-20.2%

↓

Gross Margin

24.9%

↓

Debt/Equity

1.53

↑
52-Week Range$525
$400$1240

TradingView lightweight chart

RANC.JK price, volumen y niveles de valoración

Último $525.00Periodo -21.6%
Fair value: $525.00

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2024–2025 · 1 años de histórico normalizado

Revenue CAGR

+1.4%

FCF CAGR

+177.1%

FCF margin

2.2%

FCF / Net income

-1.21x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $2.91T · net income $-53.09B · FCF $64.21B

2024-FY → 2025-FY

Gross margin

24.9%+0.3% pts

Operating margin

-0.5%+0.8% pts

Net margin

-1.8%-2.8% pts

FCF margin

2.2%+1.4% pts
MetricTTM
2025
2024
Income Statement
Revenue$2914.55B$2914.55B$2874.07B
Net Income$-53.09B$-53.09B$27.38B
EBITDA$136.46B$136.46B$239.89B
EPS-34.00-34.0018.00
Gross Margin24.9%24.9%24.6%
Operating Margin-0.5%-0.5%-1.3%
Net Margin-1.8%-1.8%1.0%
Balance Sheet
Debt/Equity1.531.531.16
Current Ratio0.900.90—
Cash Flow
Free Cash Flow$64.21B$64.21B$23.18B
Returns
ROE-20.2%-20.2%8.6%
Valuation
P/E——25.78
EV/EBITDA8.398.394.13
P/B3.123.122.27
Growth & Yield
Revenue Growth1.4%1.4%—
EPS Growth-288.9%-288.9%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +20.4%

Total return

+20.4%

Start / end P/E

n/dx → n/dx

EPS bridge

18.00 → -34.00

Residual

+20.4%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+20.4%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.